1. Home
  2. VKTX vs TGLS Comparison

VKTX vs TGLS Comparison

Compare VKTX & TGLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VKTX
  • TGLS
  • Stock Information
  • Founded
  • VKTX 2012
  • TGLS 1984
  • Country
  • VKTX United States
  • TGLS Colombia
  • Employees
  • VKTX N/A
  • TGLS N/A
  • Industry
  • VKTX Biotechnology: Pharmaceutical Preparations
  • TGLS Electronic Components
  • Sector
  • VKTX Health Care
  • TGLS Consumer Discretionary
  • Exchange
  • VKTX Nasdaq
  • TGLS Nasdaq
  • Market Cap
  • VKTX 3.0B
  • TGLS 3.2B
  • IPO Year
  • VKTX 2015
  • TGLS 2012
  • Fundamental
  • Price
  • VKTX $33.65
  • TGLS $64.60
  • Analyst Decision
  • VKTX Strong Buy
  • TGLS Buy
  • Analyst Count
  • VKTX 12
  • TGLS 3
  • Target Price
  • VKTX $86.42
  • TGLS $83.33
  • AVG Volume (30 Days)
  • VKTX 5.3M
  • TGLS 340.2K
  • Earning Date
  • VKTX 10-22-2025
  • TGLS 11-06-2025
  • Dividend Yield
  • VKTX N/A
  • TGLS 0.94%
  • EPS Growth
  • VKTX N/A
  • TGLS 24.86
  • EPS
  • VKTX N/A
  • TGLS 3.89
  • Revenue
  • VKTX N/A
  • TGLS $955,734,000.00
  • Revenue This Year
  • VKTX N/A
  • TGLS $14.92
  • Revenue Next Year
  • VKTX N/A
  • TGLS $11.24
  • P/E Ratio
  • VKTX N/A
  • TGLS $16.39
  • Revenue Growth
  • VKTX N/A
  • TGLS 16.89
  • 52 Week Low
  • VKTX $18.92
  • TGLS $60.25
  • 52 Week High
  • VKTX $81.73
  • TGLS $90.34
  • Technical
  • Relative Strength Index (RSI)
  • VKTX 62.67
  • TGLS 29.43
  • Support Level
  • VKTX $25.04
  • TGLS $65.35
  • Resistance Level
  • VKTX $32.85
  • TGLS $67.48
  • Average True Range (ATR)
  • VKTX 1.49
  • TGLS 1.57
  • MACD
  • VKTX 1.01
  • TGLS -0.25
  • Stochastic Oscillator
  • VKTX 88.54
  • TGLS 0.00

About VKTX Viking Therapeutics Inc.

Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.

About TGLS Tecnoglass Inc.

Tecnoglass Inc is a manufacturer of hi-spec architectural glass and windows for residential and commercial construction industries, operating through its direct and indirect subsidiaries. Its product offerings include tempered glass, laminated glass, thermo-acoustic glass, sliding windows, projecting windows, guillotine windows, sliding doors, loating facades, automatic doors, bathroom dividers, and commercial display windows, among others. The company has one operating segment, Architectural Glass and Windows, which is also its reporting segment. Geographically, the company generates maximum revenue from its customers in the United States, followed by Colombia, Panama, and other regions.

Share on Social Networks: